BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
100 hedge funds and large institutions have $150M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $189M → $150M (-$39.4M)
Holders
100
Holding in Top 10
–
Calls
$942K
Puts
$314K
Top Buyers
| 1 | +$2.16M | |
| 2 | +$2.07M | |
| 3 | +$2.04M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$925K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$677K |
Top Sellers
| 1 | -$9.58M | |
| 2 | -$4.49M | |
| 3 | -$864K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$709K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$690K |